We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > statement

News List

Statement by FDA Commissioner on Agency's Work to Address Opioid Crisis americanpharmaceuticalreview
August 30, 2018
Over the past 17 months, we've set out to address the opioid crisis forcefully, using all the agency's tools and authorities.
Statement by FDA Commissioner on Formation of New Work Group americanpharmaceuticalreview
July 24, 2018
As part of our public health mission, the Food and Drug Administration (FDA) monitors the pharmaceutical supply chain to support patient access to medically necessary drugs.
Statement by FDA Commissioner on Balancing Access to Pain Treatment with Opioid Misuse americanpharmaceuticalreview
July 11, 2018
The opioid epidemic continues to take an emotional, physical and financial toll on Americans. The U.S. Food and Drug Administration is committed to taking every possible step to address the many facets of this complex public health crisis.